Author

C. Nnabuife

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:bacteria (other)· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

T. Palzkill· 2 shared A. Khalil· 1 shared C. N. Abbott· 1 shared C. Ye· 1 shared D. S. Weiss· 1 shared D. von Laer· 1 shared E. Heilmann· 1 shared F. Costacurta· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

T. Palzkill

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Transmissible SARS-CoV-2 variants with resistance to clinical protease inhibitors

S. A. Moghadasi, E. Heilmann, A. Khalil, C. Nnabuife, F. Kearns, C. Ye, S. N. Moraes, F. Costacurta, M. Esler, H. Aihara, D. von Laer, L. Martinez-Sobrido, T. Palzkill, R. E. Amaro, R. Harris

The paper identifies SARS-CoV-2 variants resistant to protease inhibitors nirmatrelvir and ensitrelvir, showing pre-existing resistance and potential for spread.

Science Advances · Mar 31, 2023Peer-reviewedMicrobiology

Copy number flexibility facilitates heteroresistance to increasing antibiotic pressure and threatens the beta-lactam pipeline

J. E. Choby, T. Ozturk, C. N. Abbott, C. Nnabuife, J. M. Colquhoun, S. W. Satola, P. N. Rather, T. Palzkill, D. S. Weiss

The paper shows how bacteria use copy number flexibility of ESBLs to develop heteroresistance to new antibiotics like cefiderocol, threatening beta-lactam effectiveness.

bioRxiv · Jun 7, 2022Microbiology